TY  - JOUR 
AU  - Hernandez, M. V.
AU  - Sanchez-Piedra, C.
AU  - Garcia-Magallon, B.
AU  - Cuende, E.
AU  - Manero, J.
AU  - Campos-Fernandez, C.
AU  - Martin-Domenech, R.
AU  - Del Pino-Montes, J.
AU  - Manrique, S.
AU  - Castro-Villegas, M. C.
AU  - Ruiz-Montesinos, D.
AU  - Sanchez-Alonso, F.
AU  - Diaz-Gonzalez, F.
AU  - Cea-Calvo,
AU  - Gómez Reino, Juan J
PY  - 2019
SN  - 0172-8172
UR  - http://hdl.handle.net/20.500.11940/15473
AB  - The retention rate of a biological drug (percentage of patients remaining on treatment over time) provides an index of a drug's overall effectiveness. The golimumab retention rate as first-line biological therapy was high in clinical trial extensions...
LA  - eng
TI  - Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry
DO  - 10.1007/s00296-018-4177-z
T2  - RHEUMATOLOGY INTERNATIONAL
M2  - 509
KW  - CHUS
VL  - 39
ER  -